Center for Scientific Review; Notice of Closed Meetings, 67747-67748 [2020-23583]
Download as PDF
<![CDATA[
Federal Register / Vol. 85, No. 207 / Monday, October 26, 2020 / Notices
clinical data in light of the Task Force
recommendations. The Committee has
invited a representative of the new
Office of Burden Reduction and Health
Informatics, Centers for Medicare and
Medicaid Services, to provide an update
on the work of the Office and the
potential intersection with the NCVHS
work plan.
The Subcommittee on Privacy,
Confidentiality, and Security will
provide an update on the September 14,
2020, hearing that focused on data
collection and use during a public
health emergency and identify next
steps for development of guidelines for
methods and approaches to collect, use,
protect, and share data responsibly
during a pandemic or long-term
nationwide public health emergency.
Members will consider major themes
for the NCVHS 14th Report to Congress,
which is planned for release in the first
half of 2021. Members will consider and
discuss priorities for Committee focus
and revise the Committee work plan
based on the two days of meeting
proceedings.
A public comment period will be
offered on both days. Meeting times and
topics are subject to change. Please refer
to the agenda posted at the NCVHS
website for any updates.
Contact Person for More Information:
Substantive program information may
be obtained from Rebecca Hines, MHS,
Executive Secretary, NCVHS, National
Center for Health Statistics, Centers for
Disease Control and Prevention, 3311
Toledo Road, Hyattsville, Maryland
20782, or via electronic mail to vgh4@
cdc.gov; or by telephone (301) 458–
4715. Summaries of meetings and a
roster of Committee members are
available on the home page of the
NCVHS website, https://ncvhs.hhs.gov/,
where further information including an
agenda and instructions to access the
broadcast of the meeting will also be
posted.
Should you require reasonable
accommodation, please contact the CDC
Office of Equal Employment
Opportunity on (770) 488–3210 as soon
as possible.
Sharon Arnold,
Associate Deputy Assistant Secretary for
Planning and Evaluation, Science and Data
Policy, Office of the Assistant Secretary for
Planning and Evaluation.
[FR Doc. 2020–23668 Filed 10–23–20; 8:45 am]
BILLING CODE 4150–05–P
VerDate Sep<11>2014
17:31 Oct 23, 2020
Jkt 253001
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Library of Medicine; Amended
Notice of Meeting
Notice is hereby given of a change in
the meeting of the Special Emphasis
Panel, December 3, 2020, 9:00 a.m. to
5:30 p.m. This notice was published in
the Federal Register on September 29,
2020, 85 FR 189, Page 61020.
This notice is being amended to
change the date and time to December
17, 2020 from 10:00 a.m. to 5:30 p.m.
The meeting is closed to the public.
Dated: October 20, 2020.
Ronald J. Livingston, Jr.,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2020–23584 Filed 10–23–20; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Ocular
Surface, Cornea, Anterior Segment Glaucoma
and Refractive Error.
Date: November 17, 2020.
Time: 10:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Virtual Meeting).
Contact Person: Julius Cinque, MS,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5186,
MSC 7846, Bethesda, MD 20892, (301) 435–
1252, cinquej@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Topics in Metabolism.
PO 00000
Frm 00043
Fmt 4703
Sfmt 4703
67747
Date: November 20, 2020.
Time: 1:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Telephone Conference
Call).
Contact Person: Hui Chen, MD, Scientific
Review Officer, Center for Scientific Review,
National Institutes of Health, 6701 Rockledge
Drive, Room 6164, Bethesda, MD 20892,
(301) 435–1044, chenhui@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Small
Business: Disease Prevention and
Management, Risk Reduction and Health
Behavior Change.
Date: November 23, 2020.
Time: 9:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Michael J McQuestion,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3114
MSC 7808, Bethesda, MD 20892, (301) 480–
1276, mike.mcquestion@nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; PAR–19–
367: Maximizing Investigators’ Research
Award (R35—Clinical Trial Optional).
Date: November 23–24, 2020.
Time: 10:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: David Balasundaram,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5189,
MSC 7840, Bethesda, MD 20892, (301) 435–
1022, balasundaramd@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; PAR–20–
131: Mammalian Models for Translational
Research.
Date: November 23, 2020.
Time: 10:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Malaya Chatterjee, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health,6701 Rockledge Drive, Room 6192,
MSC 7804, Bethesda, MD 20892, (301) 806–
2515, chatterm@csr.nih.gov.
Name of Committee: Infectious Diseases
and Microbiology Integrated Review Group;
HIV Molecular Virology, Cell Biology, and
Drug Development Study Section.
Date: November 23–24, 2020.
Time: 10:00 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
E:\FR\FM\26OCN1.SGM
26OCN1
67748
Federal Register / Vol. 85, No. 207 / Monday, October 26, 2020 / Notices
Contact Person: Kenneth A Roebuck, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5214,
MSC 7852, Bethesda, MD 20892, (301) 435–
1166, roebuckk@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Receptors and Cell Cycle.
Date: November 23, 2020.
Time: 1:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Kevin Czaplinski, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, 6701 Rockledge Drive,
Bethesda, MD 20892. (301) 435–0000,
czaplinskik2@csr.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: October 20, 2020.
Miguelina Perez,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2020–23583 Filed 10–23–20; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
The National Institutes of Health (NIH)
Sexual & Gender Minority Research
Listening Session
AGENCY:
National Institutes of Health,
HHS.
ACTION:
Notice.
The National Institutes of
Health (NIH) Sexual & Gender Minority
Research Office (SGMRO) will be
holding its second annual listening
session with Sexual & Gender Minority
(SGM)-focused organizations. The
primary objective of the NIH’s listening
session is to hear from community
stakeholders about what issues are on
their minds regarding SGM-related
research and related activities at NIH.
The goal is to hold an annual listening
session every year, to provide different
SGM focused organizations an
opportunity to speak.
DATES: The listening session with the
SGM community will be held on
November 19, 2020, at 1:00 p.m. ET.
ADDRESSES: The meeting will be held
virtually as a WebEx Event, and it will
be open to the public to listen.
Information about the meeting and
registration to attend are at this link:
SUMMARY:
VerDate Sep<11>2014
17:31 Oct 23, 2020
Jkt 253001
https://dpcpsi.nih.gov/sgmro/listeningsession.
FOR FURTHER INFORMATION CONTACT:
Irene Avila, Ph.D., Assistant Director,
Sexual & Gender Minority Research
Office (SGMRO), 6555 Rock Spring
Drive, Rm. 2SE31J, Bethesda, MD 20817,
avilai@mail.nih.gov, 301–594–9701.
SUPPLEMENTARY INFORMATION: ‘‘Sexual
and gender minority’’ is an umbrella
term that includes, but is not limited to,
individuals who identify as lesbian, gay,
bisexual, asexual, transgender, TwoSpirit, queer, and/or intersex.
Individuals with same-sex or -gender
attractions or behaviors and those with
a difference in sex development are also
included. These populations also
encompass those who do not selfidentify with one of these terms but
whose sexual orientation, gender
identity or expression, or reproductive
development is characterized by nonbinary constructs of sexual orientation,
gender, and/or sex.
In accordance with Section 404N of
the 21st Century Cures Act (Pub. L. 114–
255), the Sexual and Gender Minority
Research Office (SGMRO) coordinates
sexual and gender minority (SGM)related research and activities by
working directly with NIH Institutes,
Centers, and Offices. The Office was
officially established in September 2015
within the NIH Division of Program
Coordination, Planning, and Strategic
Initiatives in the Office of the Director.
The SGMRO has the following
operational goals: (1) Advance rigorous
research on the health of SGM
populations in both the extramural and
intramural research communities; (2)
expand SGM health research by
fostering partnerships and
collaborations with a strategic array of
internal and external stakeholders; (3)
foster a highly skilled and diverse
workforce in SGM health research; and
(4) encourage data collection related to
SGM populations in research and the
biomedical research workforce.
Listening Session Details
The listening session event will be an
NIH-wide effort, with representation
from the SGMRO and other NIH
Institutes, Centers, and Offices. The
listening session will be open to the
public to listen in; comments submitted
via email will be accepted post-listening
session. The session will be recorded a
posted on the SGMRO website
approximately one month post-session.
Comments, questions, or feedback can
be shared with SGMRO@nih.gov.
SGMRO will invite approximately 13
SGM-focused organizations to present at
the listening session. Selection of the
PO 00000
Frm 00044
Fmt 4703
Sfmt 4703
organizations will be based on the
diversity of their missions and efforts.
Dated: October 19, 2020.
Lawrence A. Tabak,
Principal Deputy Director, National Institutes
of Health.
[FR Doc. 2020–23589 Filed 10–23–20; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Cancer
Institute Special Emphasis Panel; R13
Conference Grant Review.
Date: November 12, 2020.
Time: 10:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Cancer Institute Shady
Grove, 9609 Medical Center Drive, Room
7W552, Rockville, MD 20850 (Telephone
Conference Call).
Contact Person: Jeanette Irene Marketon,
Ph.D., Scientific Review Officer, Program
Coordination and Referral Branch, Division
of Extramural Activities, National Cancer
Institute, NIH, 9609 Medical Center Drive,
Room 7W552, Rockville, MD 20892, (240)
276–6780, jeanette.marketon@nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel; Smoking
Cessation & HIV R01/R21.
Date: November 19, 2020.
Time: 12:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Cancer Institute Shady
Grove, 9609 Medical Center Drive, Room
7W102, Rockville, MD 20850 (Telephone
Conference Call).
Contact Person: Shakeel Ahmad, Ph.D.,
Chief, Research Technology and Contract
Review Branch, Division of Extramural
Activities, National Cancer Institute, NIH,
9609 Medical Center Drive, Room 7W102,
Rockville, MD 20850, 240–276–6442,
ahmads@mail.nih.gov.
E:\FR\FM\26OCN1.SGM
26OCN1
]]>Agencies
[Federal Register Volume 85, Number 207 (Monday, October 26, 2020)]
[Notices]
[Pages 67747-67748]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-23583]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Ocular Surface, Cornea, Anterior Segment Glaucoma and
Refractive Error.
Date: November 17, 2020.
Time: 10:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Julius Cinque, MS, Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 5186, MSC 7846, Bethesda, MD 20892, (301) 435-
1252, [email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Member Conflict: Topics in Metabolism.
Date: November 20, 2020.
Time: 1:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Telephone Conference Call).
Contact Person: Hui Chen, MD, Scientific Review Officer, Center
for Scientific Review, National Institutes of Health, 6701 Rockledge
Drive, Room 6164, Bethesda, MD 20892, (301) 435-1044,
[email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Small Business: Disease Prevention and Management, Risk
Reduction and Health Behavior Change.
Date: November 23, 2020.
Time: 9:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Michael J McQuestion, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3114 MSC 7808, Bethesda, MD
20892, (301) 480-1276, [email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; PAR-19-367: Maximizing Investigators' Research Award (R35--
Clinical Trial Optional).
Date: November 23-24, 2020.
Time: 10:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: David Balasundaram, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5189, MSC 7840, Bethesda, MD
20892, (301) 435-1022, [email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; PAR-20-131: Mammalian Models for Translational Research.
Date: November 23, 2020.
Time: 10:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Malaya Chatterjee, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health,6701 Rockledge Drive, Room 6192, MSC 7804, Bethesda, MD
20892, (301) 806-2515, [email protected].
Name of Committee: Infectious Diseases and Microbiology
Integrated Review Group; HIV Molecular Virology, Cell Biology, and
Drug Development Study Section.
Date: November 23-24, 2020.
Time: 10:00 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
[[Page 67748]]
Contact Person: Kenneth A Roebuck, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5214, MSC 7852, Bethesda, MD
20892, (301) 435-1166, [email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Member Conflict: Receptors and Cell Cycle.
Date: November 23, 2020.
Time: 1:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Kevin Czaplinski, Ph.D., Scientific Review
Officer, Center for Scientific Review, 6701 Rockledge Drive,
Bethesda, MD 20892. (301) 435-0000, [email protected].
(Catalogue of Federal Domestic Assistance Program Nos. 93.306,
Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893,
National Institutes of Health, HHS)
Dated: October 20, 2020.
Miguelina Perez,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2020-23583 Filed 10-23-20; 8:45 am]
BILLING CODE 4140-01-P
